| Literature DB >> 23734250 |
Arnt Erik Tjønna1, Ingeborg Megaard Leinan, Anette Thoresen Bartnes, Bjørn M Jenssen, Martin J Gibala, Richard A Winett, Ulrik Wisløff.
Abstract
UNLABELLED: Regular exercise training improves maximal oxygen uptake (VO2max), but the optimal intensity and volume necessary to obtain maximal benefit remains to be defined. A growing body of evidence suggests that exercise training with low-volume but high-intensity may be a time-efficient means to achieve health benefits. In the present study, we measured changes in VO2max and traditional cardiovascular risk factors after a 10 wk. training protocol that involved three weekly high-intensity interval sessions. One group followed a protocol which consisted of 4×4 min at 90% of maximal heart rate (HRmax) interspersed with 3 min active recovery at 70% HRmax (4-AIT), the other group performed a single bout protocol that consisted of 1×4 min at 90% HRmax (1-AIT). Twenty-six inactive but otherwise healthy overweight men (BMI: 25-30, age: 35-45 y) were randomized to either 1-AIT (n = 11) or 4-AIT (n = 13). After training, VO2max increased by 10% (∼5.0 mL⋅kg(-1)⋅min(-1)) and 13% (∼6.5 mL⋅kg(-1)⋅min(-1)) after 1-AIT and 4-AIT, respectively (group difference, p = 0.08). Oxygen cost during running at a sub-maximal workload was reduced by 14% and 13% after 1-AIT and 4-AIT, respectively. Systolic blood pressure decreased by 7.1 and 2.6 mmHg after 1-AIT and 4-AIT respectively, while diastolic pressure decreased by 7.7 and 6.1 mmHg (group difference, p = 0.84). Both groups had a similar ∼5% decrease in fasting glucose. Body fat, total cholesterol, LDL-cholesterol, and ox-LDL cholesterol only were significantly reduced after 4-AIT. Our data suggest that a single bout of AIT performed three times per week may be a time-efficient strategy to improve VO2max and reduce blood pressure and fasting glucose in previously inactive but otherwise healthy middle-aged individuals. The 1-AIT type of exercise training may be readily implemented as part of activities of daily living and could easily be translated into programs designed to improve public health. TRIAL REGISTRATION: ClinicalTrials.govNCT00839579.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23734250 PMCID: PMC3667025 DOI: 10.1371/journal.pone.0065382
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow chart of the study design.
Subjects baseline values (mean, SD), and mean within group change (95% CI) post exercise intervention.
| BL 1-AIT | Post 1-AIT | BL 4-AIT | Post 4-AIT | P-value | |
|
| 41.8±3.6 | 42.2±2.4 | |||
|
| |||||
| Height, cm | 185±6.9 | 179±8.4 | |||
| Weight, kg | 95.1±5.0 | −1.8 (−3.3, −0.3) | 85.9±8.9 | −2.1 (−3.2, −1.1) | 0.19 |
| BMI, kg/m2 | 27.8±1.8 | −0.4 (−0.7, −0.1) | 27.0±2.1 | −0.7 (−0.9, −0.4) | 0.56 |
| Fat percent, % | 25.7±3.6 | −0.6 (−1.2, 0.1) | 23.0±2.9 | −0.8 (−1.4, −0.2) | 0.89 |
| Fat weight trunk, kg | 13.2±1.7 | −0.5 (−1.3, 0.3) | 10.6±2.1 | −0.9 (−1.6, −0.3) | 0.62 |
| Fat weight total, kg | 24.5±2.9 | −0.7 (−1.7, 0.3) | 19.9±3.5 | −1.1 (−1.9, −0.3) | 0.98 |
|
| |||||
| VO2max,, mL · kg−1 · min−1 | 39.5±5.1 | 4.5 (2.4, 6.5) | 44.8±5.1 | 7.0 (5.1, 8.8) | 0.08 |
|
| |||||
| Flow mediated dilatation, % | 4.85±3.7 | −0.5 (−1.9, 1.0) | 5.62±4.17 | −0.8 (−2.2, 0.5) | 0.75 |
| Systolic Blood Pressure, mmHg | 142.4±17.6 | −6.2 (−11.4, −0.9) | 136.3±11.7 | −3.2 (−8.1, 1.7) | 0.84 |
| Diastolic Blood Pressure, mmHg | 91.9±8.7 | −7.7 (−15.1, −0.3) | 88.4±7.1 | −6.3 (−13.2, 0.5) | 0.79 |
| Mean arterial blood pressure, mmHg | 108.7±11.2 | −7.2 (−13.0, −1.4) | 104.4±7.8 | −5.1 (−10.5, 0.3) | 0.99 |
|
| |||||
| Triglyceride, mmol · L−1 | 1.21±0.47 | 0.12 (−0.16, 0.39) | 1.22±0.60 | 0.07 (−0.19, 0.33) | 0.77 |
| HDL-cholesterol, mmol • L−1 | 1.31±0.27 | −0.06 (−0.15, 0.04) | 1.47±0.44 | −0.11 (−0.19, −0.02) | 0.41 |
| Fasting Glucose, mmol • L−1 | 5.13±0.41 | −0.35 (−0.61, −0.08) | 5.28±0.34 | −0.25 (−0.49, −0.01) | 0.80 |
| Hemoglobin, g • dL−1 | 15.3±0.69 | −0.07 (−0.36, 0.23) | 15.5±0.83 | −0.20 (−0.46, 0.07) | 0.48 |
| Cholesterol, mmol • L−1 | 6.56±1.36 | −0.31 (−0.92, 0.31) | 6.36±0.95 | −0.54 (−1.10, 0.03) | 0.71 |
| LDL-cholesterol, mmol • L−1 | 4.70±1.30 | −0.29 (−0.85, 0.27) | 4.34±0.86 | −0.44 (−0.96, 0.08) | 0.96 |
| ox-LDL cholesterol, U/L | 101.2±24.2 | −6.36 (−13.11, 0.39) | 98.3±15.5 | −14.77 (−20.98, −8.56) | 0.07 |
| HbA1c, % | 5.44±0.19 | 0.09 (0.02, 0.17) | 5.51±0.17 | 0.13 (0.07, 0.19) | 0.36 |
| C-peptide, nmol • L−1 | 0.72±0.38 | −0.03 (−0.20, 0.14) | 0.58±0.30 | −0.01 (−0.18, 0.15) | 0.67 |
| CRP, mg • L−1 | 2.26±1.70 | −0.54 (−0.97, −0.10) | 1.64±1.74 | −0.98 (−1.38, −0.58) | 0.36 |
Baseline data are presented as mean ± SD. Post values are mean within group change (95% CI) after exercise intervention. P-values are from mixed model analyses after adjusting for baseline values. BL; baseline. HbA1c; glycosylated hemoglobin. CRP: c - reactive protein, FMD; flow mediated dilatation (1-AIT, n = 11; 4-AIT, n = 13).
Figure 2Maximal oxygen uptake (VO2max) (A). Maximal oxygen pulse (B). Work economy presented as submaximal oxygen uptake (C). Data represents mean (SD).